Researchers launched a unique collaboration on Wednesday aimed at getting cancer drugs to the market more quickly in which three companies will cooperate with the U.S. government and non-profit groups to test five experimental breast cancer drugs.
The five-year, $26 million study called Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis, or I-SPY2, will aim to use DNA to match the best drug to each patient and to more quickly toss out approaches that do not work or are too toxic.
"They'll get the latest and greatest in terms of targeted drugs," Dr. Anna Barker, deputy director of the National Cancer Institute, said in an interview.
"I think it's the future. Government couldn't have done it on their own and these companies couldn't have done it on their own."
Unusually, the companies agreed to share information on using genes to predict how well a patient will respond as part of the Biomarkers Consortium, which includes the U.S. Food and Drug Administration and the National Institutes of Health.
"I-SPY 2 will provide a path to personalized medicine," said Dr. Laura Esserman, a breast cancer surgeon at the University of California San Francisco who will help lead the clinical trials. "We intend that every drug will graduate with a companion marker."
The trial will match patients to one of five experimental drugs:
-- ABT-888 or veliparib, being developed by Abbott Laboratories. The pill is a PARP inhibitor, which blocks a cell repair enzyme used by cancer cells.
-- AMG 655 or conatumumab, a targeted drug being developed by Amgen. It boosts a protein called APO/TRAIL that causes cancer cells to self-destruct.
-- Amgen's AMG 386, an angiogenesis inhibitor that stops tumors from growing blood vessels to nourish themselves.
-- CP-751,871 or figitumumab, being developed by Pfizer Inc to target the insulin growth factor receptor or IGFR.
-- Pfizer's HKI-272 or neratinib, another targeted therapy called a Pan ErbB inhibitor that targets several related receptors used by cancer cells.
The group is negotiating with other companies to add their experimental drugs to the mix.
"It'll speed up the whole process," Barker said.
The drug company lobby group PhRMA estimates it can take as long as 15 years and cost more than $1.3 billion dollars to take a new drug from laboratory to pharmacy.
Patients at 20 cancer centers will be tested right after they get tiny samples of tissue taken in biopsies. Before they ever get surgery, they will be treated with one of the drugs to see if this helps prevent tumor spread.
Up to 12 different cancer drugs will be tested. Unusually, the group has FDA approval to drop and add drugs throughout the course of the trial without having to stop it to write a whole new protocol.
Mali's last infected patient recovered and left hospital last week, while the remaining individuals who came in contact with an infected person finished a mandatory 21-day quarantine
The young man, who hails from the southern city of Khan Younis, was the Gaza Strip's first H1N1 fatality
The text appeased developing countries, including China and India, concerned that previous drafts would impose too heavy a burden on emerging economies
Global environmental umbrella organization designates country as most backward at UN climate conference in Lima.
Ship carrying 1,500 tons of food and medical supplies heads to Ebola-hit West Africa who is need of urgent medical supplies.
Peru has more tropical glaciers than any other nation but rising temperatures linked to global warming have helped shrink the ice masses by up to 40 percent
Pesticide poisoning causes inability to breathe, chemical burns, loss of reflexes, twitching, and ultimately death, experts say
The human safety trials, which began in Geneva on Nov. 10, are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that joint pain symptoms in hands and feet were "benign and temporary"
The Nazca Lines are a set of giant images of plants and animals, such as a monkey, a spider and a hummingbird, excavated in the soil some 1,500 years ago.
Experts have sounded the alarm in recent years over how plastic pollution is killing huge numbers of seabirds, marine mammals and other creatures while sullying ocean ecosystems.
Nine months into the worst Ebola outbreak on record, Ebola is still spreading in Sierra Leone and parts of Guinea.
The death toll from the Ebola outbreak in West Africa has risen to 6,331 in the three worst hit countries, with Sierra Leone overtaking Liberia as the country with the highest number of cases
A total of 140 cases of measles had been reported whilst 6 people have died from the disease according to the Egyptian Health Ministry
The Ethiopian government is in the middle of a biannual spike in malaria as it seeks to control the epidemic.
Several countries in Latin America have seen a rapid reduction of their forests in the last years, as logging, agriculture and mining activities expanded quickly.
Felix Baez received the Canadian experimental treatment ZMab, a precursor to the Ebola drug ZMapp, which has been used to treat several U.S. patients.